Autopsy report · NCT03968237

Measures to Improve Outcomes After an Opioid Overdose

“COVID-19 pandemic interfered with ability to conduct study.”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Sponsor

Nassima Ait-Daoud Tiouririne

Sponsor type

University, hospital or other

Conditions

Opioid Overdose

Interventions

Buprenorphine/Naloxone

Participants

0

Sites

1

Countries

United States

Trials that died the same way

• Altering Mechanisms of Frailty in Persons Living With HIV Aged 50 to 65
  “COVID-19 prevented us from doing this human subjects study” (81% match in meaning)
• Improving 24-hour Blood Pressure in Obstructive Sleep Apnea
  “Covid-19 Pandemic prevented this study from beginning” (74% match in meaning)
• The Georgia Latino AIDS/HIV Diagnosis and Linkage in Youth (GLADLY) Project
  “The study was not able to be completed due to the COVID-19 pandemic.” (72% match in meaning)
• Study Evaluating Subjects With Distal Renal Tubular Acidosis
  “COVID-19 pandemic negatively impacted the ability to enroll patients.” (72% match in meaning)
• Effects of Short-term Choir Participation on Auditory Perception in Hearing-aided Older Adults.
  “COVID-19 forced the shut down of the study” (72% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.